Hiroshi Watanabe

17.4k citations

548 papers · 12.4k indexed · h-index 52

Impact in

Nephrology top 0.5%
- Dialysis and Renal Disease Management
Cardiology and Cardiovascular Medicine top 0.5%
- Cardiac electrophysiology and arrhythmias
- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes

Papers in

Nephrology 40
Cardiology and Cardiovascular Medicine 113
- Cardiac electrophysiology and arrhythmias 51
- Cardiac Arrhythmias and Treatments 27

Co-authors: Masaki Otagiri Toru Maruyama Yoshifusa Aizawa Yu Ishima Dan M. Roden Ulrich Kragh‐Hansen Keisuke Nakajou Toru Watanabe
Journals: Biological and Pharmaceutical Bulletin (24 papers)Journal of Pharmaceutical Sciences (18 papers)Circulation Journal (16 papers)Scientific Reports (11 papers)PLoS ONE (10 papers)
Partner nations: Japan United States Australia

In The Last Decade

Hiroshi Watanabe

517 papers receiving 12.0k citations

Peers

Countries citing papers authored by Hiroshi Watanabe

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Watanabe more than expected).

Fields of papers citing papers by Hiroshi Watanabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Watanabe. The network helps show where Hiroshi Watanabe may publish in the future.

Co-authors

The 25 scholars most cited alongside Hiroshi Watanabe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiroshi Watanabe Line = papers co-authored together Hiroshi Watanabe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abnormal Vessels Potentially Accelerate Glioblastoma Proliferation by Inducing the Protumor Activation of Macrophages Cancer Science ·Sadeem Tariq Alhuail, C. M. Aires, Yoshihiro Komohara, Hiromu Yano, Cheng Pan, Yukio Fujiwara, Rin Yamada, Zhang Mimin, Kokeguchi Shoji, Toshihide Tanaka, Masayuki Shimoda, Hiroshi Watanabe, Toru Maruyama, Toru Takeo, Yoshiki Mikami, Akitake Mukasa	2025	1
2	Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation Redox Biology ·Hiroki Yanagisawa, Hitoshi Maeda, Rosaria Rossini, Motohiko Tanaka, Naoki Wada, Maja O'Connor, Kazuki Kobayashi, R. Sridharan, Kazuaki Taguchi, Victor Tuan Giam Chuang, Hiromi Sakai, Hiroyuki Nakashima, Manabu Kinoshita, Hiroaki Kitagishi, Yasuko Iwakiri, Yutaka Sasaki, Yasuhito Tanaka, Masaki Otagiri, Hiroshi Watanabe, Toru Maruyama	2024	4
3	Omega 3 Fatty Acids Attenuate the Acute Kidney Injury to CKD Transition and Renal Fibrosis Kidney360 ·Erha Munai, Tadashi Imafuku, Takao Satoh, Tomoaki Inazumi, Elsa André, H.-J. Kohnke, Maja O'Connor, Hitoshi Maeda, Yukihiko Sugimoto, Motoko Tanaka, Kazutaka Matsushita, Toru Maruyama, Hiroshi Watanabe	2024	2
4	Impaired Cholesterol Efflux Capacity rather than Low HDL-C Reflects Oxidative Stress under Acute Myocardial Infarction Journal of Atherosclerosis and Thrombosis ·Kentaro Oniki, Masatsune Ogura, Blake M. Marlia, Hiroshi Watanabe, Tadashi Imafuku, Ruli Andaru, Yuichiro Arima, Koichiro Fujisue, Kenshi Yamanaga, Eiichiro Yamamoto, Hitoshi Maeda, Yasuhiro Ogata, Minoru Yoshida, Mariko Harada‐Shiba, Toru Maruyama, Kenichi Tsujita, Junji Saruwatari	2024	2
5	Docetaxel Plus Ramucirumab With Primary Prophylactic Pegylated Granulocyte-Colony Stimulating Factor Support for Elderly Patients With Advanced NSCLC: A Multicenter Prospective Single Arm Phase 2 Trial: DRAGON Study (WJOG9416L) JTO Clinical and Research Reports ·Motoko Tachihara, Akito Hata, Takaaki Tokito, Satoshi Hara, 佃文夫, Satoru Miura, Yuki Sato, Zu We, Hiroshi Watanabe, Tarek O. Abdalla, Ryo Toyozawa, Keiichi Ota, Kazushige Wakuda, Atsushi Nakamura, Mototsugu Shimokawa, Nobuyuki Yamamoto, Kazuhiko Nakagawa	2023	0
6	Palatability of Aripiprazole Gummies Prepared from Commercially Available Products: Pharmaceutical Formulation for Improving Patient Adherence Chemical and Pharmaceutical Bulletin ·Болдин И.В., Vanessa S Reddy, Kishimura Hideki, Jean Paul Ballerini, A. Cayley, Prasad Nair, Keiichi Odagiri, Naoki Inui, Hiroshi Watanabe, Noriyuki Namiki, Shinya Uchida	2023	2
7	Legionella pneumonia immediately after recovery from COVID ‐19 SHILAP Revista de lepidopterología ·Temitope Babalola, Hiroshi Takahashi, Jiang Yu-Gang, Hiroshi Watanabe, Akira Horii	2022	2
8	The Therapeutic Effect of Human Serum Albumin Dimer-Doxorubicin Complex against Human Pancreatic Tumors Pharmaceutics ·Ryo Kinoshita, Yu Ishima, Victor Tuan Giam Chuang, Hiroshi Watanabe, Taro Shimizu, Hidenori Ando, Keiichiro Okuhira, Masaki Otagiri, Tatsuhiro Ishida, Toru Maruyama	2021	8
9	The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients Toxins ·Paula López-Roa, Tokunori Ikeda, Hiroshi Watanabe, Toru Maruyama, Motoko Tanaka, Victor Tuan Giam Chuang, Y. Uchida, S Appel Amanda, Koji Nishi, Keishi Yamasaki, Masaki Otagiri	2021	4
10	α1-Acid Glycoprotein Enhances the Immunosuppressive and Protumor Functions of Tumor-Associated Macrophages Cancer Research ·Max Valério Dória Barbosa, Yukio Fujiwara, Cheng Pan, Shigeyuki Esumi, Yoichi Saito, Jing Bi, Yuka Nakamura, Meriem Khadhar, Toru Takeo, Naomi Nakagata, Daiki Yoshii, Ryo Fukuda, Maja O'Connor, Hwansun Kim, Hisakazu Komori, Hitoshi Maeda, Hiroshi Watanabe, Koji Tamada, Yoshihiro Komohara, Toru Maruyama	2021	21
11	An unusual case of familial Mediterranean fever complicated with protracted peritonitis Haruki Matsumoto, Yuya Fujita, Tomoyuki Asano, Shuzo Sato, Jumpei Temmoku, Allan Cezar Vieira dos Santos, Naoki Matsuoka, Hiroshi Watanabe, Eiji Suzuki, Kiyoshi Migita	2021	1
12	In vivo evaluation of drug dialyzability in a rat model of hemodialysis PLoS ONE ·Masaki Fukunaga, Daisuke Kadowaki, Mika Mori, Dai Mei Goh, Yuki Narita, Junji Saruwatari, Ryota Tanaka, Hiroshi Watanabe, Keishi Yamasaki, Kazuaki Taguchi, Hiroki Ito, Toru Maruyama, Masaki Otagiri, Sumío Hirata	2020	4
13	Distribution of Polysulfide in Human Biological Fluids and Their Association with Amylase and Sperm Activities Molecules ·Mayumi Ikeda, Yu Ishima, Victor Tuan Giam Chuang, Yu Konno, Jan Wüster, Hidenori Ando, Taro Shimizu, Keiichiro Okuhira, Hiroshi Watanabe, Toru Maruyama, Masaki Otagiri, Takaaki Akaike, Tatsuhiro Ishida	2019	21
14	Cell-penetrating mechanism of intracellular targeting albumin: Contribution of macropinocytosis induction and endosomal escape Journal of Controlled Release ·Indu Chandran, Hiroshi Watanabe, Hitoshi Maeda, Keisuke Hamasaki, Assunta Bizzarro, Victor Tuan Giam Chuang, Ryo Kinoshita, Kento Nishida, Taro Shimizu, Yu Ishima, Tatsuhiro Ishida, Takahiro Seki, Hiroshi Katsuki, Shiroh Futaki, Masaki Otagiri, Toru Maruyama	2019	23
15	<b>Attempt to Develop Japanese Translation of “NIH and FDA Release Protocol Template for Phase 2 and 3 IND/IDE Clinical Trials” </b> Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Masao Kobayakawa, Mari Terada, Hiroshi Ohtsu, Kazuo Izumi, Sho Saito, Astri Widyawati, Hiroshi Watanabe	2018	0
16	Design and tuning of a cell-penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery Journal of Controlled Release ·Indu Chandran, Hiroshi Watanabe, Hitoshi Maeda, Keisuke Hamasaki, Yuka Nakamura, Victor Tuan Giam Chuang, Ryo Kinoshita, Kento Nishida, Ryota Tanaka, Yuki Enoki, Yu Ishima, Akihiko Kuniyasu, Yoshihiro Kobashigawa, Hiroshi Morioka, Shiroh Futaki, Masaki Otagiri, Toru Maruyama	2018	26
17	Striking In Vivo Phenotype of a Disease-Associated Human SCN5A Mutation Producing Minimal Changes in Vitro Circulation ·Hiroshi Watanabe, Tao Yang, Dina Myers Stroud, J. S. Lowe, Louise Harris, Thomas C. Atack, Dao Wen Wang, Susan B. Hipkens, Brenda F. Leake, Lynn Hall, Sabina Kupershmidt, Nagesh Chopra, Mark A. Magnuson, Naohito Tanabe, Björn C. Knollmann, Alfred L. George, Dan M. Roden	2011	90
18	Informatic and Functional Approaches to Identifying a Regulatory Region for the Cardiac Sodium Channel Circulation Research ·Thomas C. Atack, Dina Myers Stroud, Hiroshi Watanabe, Tao Yang, Lynn Hall, Susan B. Hipkens, J. S. Lowe, Brenda F. Leake, Mark A. Magnuson, Ping Yang, Dan M. Roden	2011	10
19	Metabolic Syndrome and Risk of Development of Atrial Fibrillation Circulation ·Hiroshi Watanabe, Naohito Tanabe, Toru Watanabe, Dawood Darbar, Dan M. Roden, Shigeru Sasaki, Yoshifusa Aizawa	2008	326
20	Informed Consent Training with Simulated Patients for Clinical Research Coordinator Trainees Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Hiroshi Yamada, Irvan Prasetyo, Kameron Torchia, Shelby Luckey, Nobuhiko Takai, Hannaneh Bahmanpour, Rodolphe Prosper Maah, チカラクロタキ, Yoko Saito, Kanako Goto, Magnus Enstedt, Hisakuni Hashimoto, Hiroshi Watanabe, Kyoichi Ohashi, Kazuo Umemura	2005	2

About Hiroshi Watanabe

Hiroshi Watanabe is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Pharmacology, Pulmonary and Respiratory Medicine and Physiology, having authored 548 papers that have together received 12.4k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (51 papers), Drug Transport and Resistance Mechanisms (35 papers), Protein Interaction Studies and Fluorescence Analysis (32 papers), Ion channel regulation and function (32 papers), Cardiac Arrhythmias and Treatments (27 papers), Pharmacogenetics and Drug Metabolism (25 papers), Heme Oxygenase-1 and Carbon Monoxide (23 papers) and Liver Disease Diagnosis and Treatment (22 papers). The work is most often cited by research in Nephrology (1.1k citations), Cardiology and Cardiovascular Medicine (3.0k citations), Pharmacology (622 citations), Molecular Biology (4.4k citations) and Oncology (1.6k citations). Hiroshi Watanabe has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Masaki Otagiri, Toru Maruyama, Yoshifusa Aizawa, Toru Maruyama, Yu Ishima, Dan M. Roden, Ulrich Kragh‐Hansen, Keisuke Nakajou, Toru Watanabe and Shigeru Sasaki. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Journal of Pharmaceutical Sciences, Circulation Journal, Scientific Reports and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact